Please use this identifier to cite or link to this item:
Title: The anti-cancer agent SU4312 unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS.
Authors: Cui, W
Zhang, Z
Li, W
Hu, S
Mak, S
Zhang, H
Han, R
Yuan, S
Li, S
Sa, F
Xu, D
Lin, Z
Zuo, Z
Rong, J
Choi, TC
Lee, SMY
Han, Y 
Keywords: SU4312
Parkinson's disease
Neuronal NOS
Issue Date: 2013
Publisher: John Wiley and Sons
Source: British journal of pharmacology, 2013, v. 168, no. 5, p. 1201-1214 How to cite?
Journal: British journal of pharmacology
Abstract: Background and Purpose
SU4312, a potent and selective inhibitor of VEGF receptor-2 (VEGFR-2), has been designed to treat cancer. Recent studies have suggested that SU4312 can also be useful in treating neurodegenerative disorders. In this study, we assessed neuroprotection by SU4312 against 1-methyl-4-phenylpyridinium ion (MPP+)-induced neurotoxicity and further explored the underlying mechanisms.
Experimental Approach
MPP+-treated neurons and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated zebrafish were used to study neuroprotection by SU4312. NOS activity was assayed in vitro to examine direct interactions between SU4312 and NOS isoforms.
Key Results
SU4312 unexpectedly prevented MPP+-induced neuronal apoptosis in vitro and decreased MPTP-induced loss of dopaminergic neurons, reduced expression of mRNA for tyrosine hydroxylase and impaired swimming behaviour in zebrafish. In contrast, PTK787/ZK222584, a well-studied VEGFR-2 inhibitor, failed to prevent neurotoxicity, suggesting that the neuroprotective actions of SU4312 were independent of its anti-angiogenic action. Furthermore, SU4312 exhibited non-competitive inhibition of purified neuronal NOS (nNOS) with an IC50 value of 19.0 μM but showed little or no effects on inducible and endothelial NOS. Molecular docking simulations suggested an interaction between SU4312 and the haem group within the active centre of nNOS.
Conclusions and Implication
SU4312 exhibited neuroprotection against MPP+ at least partly via selective and direct inhibition of nNOS. Because SU4312 could reach the brain in rats, our study also offered a support for further development of SU4312 to treat neurodegenerative disorders, particularly those associated with NO-mediated neurotoxicity.
ISSN: 0007-1188 (print)
1476-5381 (online)
DOI: 10.1111/bph.12004
Appears in Collections:Journal/Magazine Article

View full-text via PolyU eLinks SFX Query
Show full item record

Page view(s)

Last Week
Last month
Checked on Jan 15, 2017


Checked on Jan 15, 2017

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.